Investigating a mitochondrial enzyme's role in heart health for patients with complex I defects

Nicotinamide nucleotide transhydrogenase and bioenergetic metabolism in complex I defective cardiac mitochondria

NIH-funded research Central Michigan University · NIH-10360118

This study is looking at how a special enzyme called NNT might help protect the hearts of people with inherited mitochondrial diseases, especially those with certain heart problems, by boosting energy in heart cells and reducing stress on them.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionCentral Michigan University NIH-funded
Lab location1 site (Mount Pleasant, United States)
Project IDNIH-10360118 on NIH RePORTER

What this research studies

This research focuses on understanding how a specific mitochondrial enzyme, nicotinamide nucleotide transhydrogenase (NNT), can help protect heart function in patients with inherited mitochondrial diseases, particularly those with complex I defects. These defects can lead to serious heart conditions like cardiomyopathy and heart failure. The study aims to explore whether enhancing the activity of NNT can improve energy production in heart cells and reduce oxidative stress, which is often exacerbated by these defects. By examining the relationship between NNT and heart metabolism, the research seeks to identify potential therapeutic strategies for affected patients.

Who could benefit from this research

Good fit: Ideal candidates for this research include children and young adults diagnosed with inherited mitochondrial diseases, particularly those with complex I defects.

Not a fit: Patients without mitochondrial diseases or those whose heart conditions are unrelated to mitochondrial dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve heart function and quality of life for patients with mitochondrial diseases.

How similar studies have performed: While the specific approach of targeting NNT in this context is novel, similar research has shown promise in understanding mitochondrial function and its impact on heart health.

Where this research is happening

Mount Pleasant, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.